Galectin Therapeutics (NASDAQ: GALT) adds to recent gains amid NASH stock takeover speculation following Allergen's (NYSE ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE